Cambridge Biolabs provides exclusive access to ultra-sensitive DNA and RNA epigenetic modification testing through a partnership with Trace Bioanalytics. We can identify epigenetic modifications such as DNA methylation.
Simultaneous detection of 50 fmol each of four IMI-labeled normal nucleotides, five DNA modifications, and an internal standard by Mass Tag Profiling
Cambridge Biolabs is designed to be a one-stop shop for startup biotechnology companies. Our partner, BioInnovation, is an investment firm with an expert administration, development and legal team. We are at your service as much or as little as you need.
Cambridge Biolabs is "your innovation lab" because our BioCloud™ model gives you lab meeting-style access to our scientific team and even hands-on control of your experiments whether you are an inventor or early stage investor.
